2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model
Lei Peng,1 Allison N Schorzman,2 Ping Ma,1 Andrew J Madden,2 William C Zamboni,2–4 Soumya Rahima Benhabbour,1 Russell J Mumper1,4 1Center for Nanotechnology in Drug Delivery, Division of Molecular Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hil...
Enregistré dans:
Auteurs principaux: | Peng L, Schorzman AN, Ma P, Madden AJ, Zamboni WC, Benhabbour SR, Mumper RJ |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8071f753f3c24c3bad81a94c0084f4b1 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo
par: Feng L, et autres
Publié: (2011) -
A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma
par: Sarah E. Woodfield, et autres
Publié: (2017) -
Biodistribution and pharmacokinetics of a telodendrimer micellar paclitaxel nanoformulation in a mouse xenograft model of ovarian cancer
par: Xiao W, et autres
Publié: (2012) -
Identification for antitumor effects of tramadol in a xenograft mouse model using orthotopic breast cancer cells
par: Myoung Hwa Kim, et autres
Publié: (2021) -
Multimodality imaging methods for assessing retinoblastoma orthotopic xenograft growth and development.
par: Timothy W Corson, et autres
Publié: (2014)